ArticleHealthcare (Basel, Switzerland)2022

Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation.

Luis D'Marco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.